399 related articles for article (PubMed ID: 24040964)
41. Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia.
Edin ML; Hamedani BG; Gruzdev A; Graves JP; Lih FB; Arbes SJ; Singh R; Orjuela Leon AC; Bradbury JA; DeGraff LM; Hoopes SL; Arand M; Zeldin DC
J Biol Chem; 2018 Mar; 293(9):3281-3292. PubMed ID: 29298899
[TBL] [Abstract][Full Text] [Related]
42. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
[TBL] [Abstract][Full Text] [Related]
43. Cytochrome P450-CYP2 Family-Epoxygenase Role in Inflammation and Cancer.
Chen C; Wang DW
Adv Pharmacol; 2015; 74():193-221. PubMed ID: 26233908
[TBL] [Abstract][Full Text] [Related]
44. Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system.
Larsen BT; Campbell WB; Gutterman DD
Trends Pharmacol Sci; 2007 Jan; 28(1):32-8. PubMed ID: 17150260
[TBL] [Abstract][Full Text] [Related]
45. Roles of the epoxygenase CYP2J2 in the endothelium.
Askari A; Thomson SJ; Edin ML; Zeldin DC; Bishop-Bailey D
Prostaglandins Other Lipid Mediat; 2013 Dec; 107():56-63. PubMed ID: 23474289
[TBL] [Abstract][Full Text] [Related]
46. Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes.
Nakayama K; Nitto T; Inoue T; Node K
Life Sci; 2008 Aug; 83(9-10):339-45. PubMed ID: 18675280
[TBL] [Abstract][Full Text] [Related]
47. Integrated omics-based pathway analyses uncover CYP epoxygenase-associated networks as theranostic targets for metastatic triple negative breast cancer.
Apaya MK; Shiau JY; Liao GS; Liang YJ; Chen CW; Yang HC; Chu CH; Yu JC; Shyur LF
J Exp Clin Cancer Res; 2019 May; 38(1):187. PubMed ID: 31072371
[TBL] [Abstract][Full Text] [Related]
48. Cardiac Disease Alters Myocardial Tissue Levels of Epoxyeicosatrienoic Acids and Key Proteins Involved in Their Biosynthesis and Degradation.
Aliwarga T; Dinh JC; Heyward S; Prasad B; Gharib SA; Lemaitre RN; Sotoodehnia N; Totah RA
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293289
[TBL] [Abstract][Full Text] [Related]
49. Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase-dependent metabolic pathways.
Wei Y; Lin DH; Kemp R; Yaddanapudi GS; Nasjletti A; Falck JR; Wang WH
J Gen Physiol; 2004 Dec; 124(6):719-27. PubMed ID: 15545402
[TBL] [Abstract][Full Text] [Related]
50. Pharmacological inhibition of the soluble epoxide hydrolase-from mouse to man.
Revermann M
Curr Opin Pharmacol; 2010 Apr; 10(2):173-8. PubMed ID: 20079692
[TBL] [Abstract][Full Text] [Related]
51. Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics.
Imig JD
Pharmacol Ther; 2018 Dec; 192():1-19. PubMed ID: 29964123
[TBL] [Abstract][Full Text] [Related]
52. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA
PLoS One; 2017; 12(3):e0174137. PubMed ID: 28328948
[TBL] [Abstract][Full Text] [Related]
53. Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium.
Vriens J; Owsianik G; Fisslthaler B; Suzuki M; Janssens A; Voets T; Morisseau C; Hammock BD; Fleming I; Busse R; Nilius B
Circ Res; 2005 Oct; 97(9):908-15. PubMed ID: 16179585
[TBL] [Abstract][Full Text] [Related]
54. Epoxyeicosatrienoic acids attenuate cigarette smoke extract-induced interleukin-8 production in bronchial epithelial cells.
Ma WJ; Sun YH; Jiang JX; Dong XW; Zhou JY; Xie QM
Prostaglandins Leukot Essent Fatty Acids; 2015 Mar; 94():13-9. PubMed ID: 25467970
[TBL] [Abstract][Full Text] [Related]
55. Origin and function of epoxyeicosatrienoic acids in vascular endothelial cells: more than just endothelium-derived hyperpolarizing factor?
Hoebel BG; Steyrer E; Graier WF
Clin Exp Pharmacol Physiol; 1998 Oct; 25(10):826-30. PubMed ID: 9784924
[TBL] [Abstract][Full Text] [Related]
56. Alteration of epoxyeicosatrienoic acids in the liver and kidney of cytochrome P450 4F2 transgenic mice.
Zhang B; Lai G; Liu X; Zhao Y
Mol Med Rep; 2016 Dec; 14(6):5739-5745. PubMed ID: 27878278
[TBL] [Abstract][Full Text] [Related]
57. Enzymatic and free radical formation of cis- and trans- epoxyeicosatrienoic acids in vitro and in vivo.
Aliwarga T; Raccor BS; Lemaitre RN; Sotoodehnia N; Gharib SA; Xu L; Totah RA
Free Radic Biol Med; 2017 Nov; 112():131-140. PubMed ID: 28734877
[TBL] [Abstract][Full Text] [Related]
58. Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk.
Theken KN; Lee CR
Pharmacogenomics; 2007 Oct; 8(10):1369-83. PubMed ID: 17979511
[TBL] [Abstract][Full Text] [Related]
59. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.
Dalle Vedove F; Fava C; Jiang H; Zanconato G; Quilley J; Brunelli M; Guglielmi V; Vattemi G; Minuz P
J Hypertens; 2016 Jul; 34(7):1364-70. PubMed ID: 27115337
[TBL] [Abstract][Full Text] [Related]
60. Role of cytochrome P450 epoxygenase in regulating renal membrane transport and hypertension.
Capdevila J; Wang W
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):163-9. PubMed ID: 23302865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
